相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting Immune Dysregulation in Myelodysplastic Syndromes
Matthew J. Olnes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care-SAKK 33/99
Jakob R. Passweg et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Immune dysregulation and dyserythropoiesis in the myelodysplastic syndromes
Fiorella Alfinito et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Immune-mediated complications in patients with myelodysplastic syndromes - clinical and cytogenetic features
Rolf Billström et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells
Melissa G. Lechner et al.
JOURNAL OF IMMUNOLOGY (2010)
Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome
M. Carlsten et al.
LEUKEMIA (2010)
Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients
A. C. Chan et al.
LEUKEMIA (2010)
DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors
Ying Liu et al.
CLINICAL IMMUNOLOGY (2009)
Therapeutic targeting of myeloid-derived suppressor cells
Stefano Ugel et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Clinical significance of regulatory T cells in patients with myelodysplastic syndrome
Wedad Hamdi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
Pierre Fenaux et al.
LANCET ONCOLOGY (2009)
Demethylating treatment suppresses natural killer cell cytolytic activity
Xiao-ning Gao et al.
MOLECULAR IMMUNOLOGY (2009)
Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplasticsyndromes (MDS)
I. Kotsianidis et al.
LEUKEMIA (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Induction of MHC class I-related chain B (MICB) by 5-aza-2′-deoxycytidine
Kai-Fu Tang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy
Elaine M. Sloand et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)
Shahram Y. Kordasti et al.
BLOOD (2007)
Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors
Pearlie K. Epling-Burnette et al.
BLOOD (2007)
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
Alan List et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: Studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B
Lewis R. Silverman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes
JJ Kiladjian et al.
LEUKEMIA (2006)
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini et al.
SEMINARS IN CANCER BIOLOGY (2006)
Immunologic abnormalities in myelodysplastic syndromes - Clinical features and characteristics of the lymphoid population
Dragomir Matisavljevic et al.
MEDICAL ONCOLOGY (2006)
Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application
T Hayashi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells
S Santourlidis et al.
JOURNAL OF IMMUNOLOGY (2002)
Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndrome
JJ Melenhorst et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B
LR Silverman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Biology of natural killer cells in cancer and infection
JS Miller
CANCER INVESTIGATION (2002)
Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process
DE Epperson et al.
LEUKEMIA RESEARCH (2001)
分享论文
